PUBLICATION

CDK9 and its repressor LARP7 modulate cardiomyocyte proliferation and response to injury in the zebrafish heart

Authors
Matrone, G., Wilson, K.S., Maqsood, S., Mullins, J.J., Tucker, C.S., Denvir, M.A.
ID
ZDB-PUB-151107-2
Date
2015
Source
Journal of Cell Science   128(24): 4560-71 (Journal)
Registered Authors
Mullins, John
Keywords
Zebrafish, CDK9, LARP7, Heart, Repair
MeSH Terms
  • Animals
  • Cell Proliferation*
  • Cyclin-Dependent Kinase 9/genetics
  • Cyclin-Dependent Kinase 9/metabolism*
  • Heart Injuries/genetics
  • Heart Injuries/metabolism*
  • Heart Injuries/pathology
  • Myocytes, Cardiac/metabolism*
  • Myocytes, Cardiac/pathology
  • RNA Polymerase II/genetics
  • RNA Polymerase II/metabolism
  • Ribonucleoproteins/genetics
  • Ribonucleoproteins/metabolism*
  • Zebrafish/genetics
  • Zebrafish/metabolism*
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism*
(all 17)
PubMed
26542022 Full text @ J. Cell Sci.
Abstract
Cyclin Dependent Kinase (CDK)9 acts via the Positive Transcription Elongation Factor-b (P-TEFb) complex to activate and expand transcription via RNA polymerase II (RNApol II). It has also been shown to regulate cardiomyocyte hypertrophy with recent evidence linking it to cardiomyocyte proliferation. We hypothesised that modification of CDK9 activity could both impair and enhance the cardiac response to injury by modifying cardiomyocyte proliferation.CDK9 expression and activity were inhibited in the zebrafish (Danio rerio) embryo. We show that dephosphorylation of the Serine2 residue on the Carboxy-Terminal domain of RNApol II (Ser2-RNApol II-CTD) is associated with impaired cardiac structure, function and cardiomyocyte proliferation and also results in impaired functional recovery following cardiac laser injury. In contrast, de-repression of CDK9 activity, by knockdown of La-related protein (LARP7) increases phosphorylation of Ser2-RNApol II-CTD and increases cardiomyocyte proliferation. LARP7 knockdown rescued the structural and functional phenotype associated with knockdown of CDK9.CDK9/LARP7-balance plays a key role in cardiomyocyte proliferation and response to injury. LARP7 represents a potentially novel therapeutic target in promoting cardiomyocyte proliferation and recovery from injury.
Genes / Markers
Marker Marker Type Name
cdk9GENEcyclin-dependent kinase 9 (CDC2-related kinase)
gata4GENEGATA binding protein 4
gata5GENEGATA binding protein 5
gata6GENEGATA binding protein 6
larp7GENELa ribonucleoprotein 7, transcriptional regulator
1 - 5 of 5
Show
Figures
Figure Gallery (4 images)
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Allele Construct Type Affected Genomic Region
f1TgTransgenic Insertion
    1 - 1 of 1
    Show
    Human Disease / Model
    No data available
    Sequence Targeting Reagents
    Target Reagent Reagent Type
    cdk9MO3-cdk9MRPHLNO
    cdk9MO13-cdk9MRPHLNO
    larp7MO2-larp7MRPHLNO
    larp7MO3-larp7MRPHLNO
    1 - 4 of 4
    Show
    Fish
    Antibodies
    Orthology
    No data available
    Engineered Foreign Genes
    Marker Marker Type Name
    GFPEFGGFP
    1 - 1 of 1
    Show
    Mapping
    No data available